Pinnacle Wealth Planning Services Inc. Takes Position in Henry Schein, Inc. $HSIC

Pinnacle Wealth Planning Services Inc. bought a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC) in the second quarter, HoldingsChannel reports. The institutional investor bought 3,207 shares of the company’s stock, valued at approximately $234,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. ANTIPODES PARTNERS Ltd bought a new position in Henry Schein in the 2nd quarter valued at about $43,000. Steph & Co. acquired a new position in shares of Henry Schein in the second quarter valued at approximately $44,000. CX Institutional increased its stake in shares of Henry Schein by 107.3% during the second quarter. CX Institutional now owns 651 shares of the company’s stock worth $48,000 after purchasing an additional 337 shares during the period. TD Private Client Wealth LLC lifted its holdings in Henry Schein by 103.0% during the 2nd quarter. TD Private Client Wealth LLC now owns 668 shares of the company’s stock worth $49,000 after purchasing an additional 339 shares during the last quarter. Finally, Quarry LP bought a new stake in Henry Schein in the 1st quarter valued at $71,000. Institutional investors and hedge funds own 96.62% of the company’s stock.

Analysts Set New Price Targets

HSIC has been the topic of several recent research reports. Morgan Stanley increased their price objective on Henry Schein from $55.00 to $58.00 and gave the stock an “underweight” rating in a research report on Wednesday, November 5th. Wall Street Zen upgraded shares of Henry Schein from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. Barrington Research set a $79.00 price objective on shares of Henry Schein and gave the stock an “outperform” rating in a research note on Wednesday, November 5th. JPMorgan Chase & Co. increased their target price on shares of Henry Schein from $76.00 to $78.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 5th. Finally, Wells Fargo & Company raised their price objective on Henry Schein from $70.00 to $76.00 and gave the stock an “equal weight” rating in a research note on Wednesday, November 5th. Five analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Henry Schein has an average rating of “Hold” and an average price target of $76.08.

Henry Schein Stock Down 0.8%

HSIC stock opened at $70.60 on Thursday. The firm has a 50-day moving average price of $66.93 and a 200-day moving average price of $69.11. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. The stock has a market capitalization of $8.31 billion, a P/E ratio of 22.77, a price-to-earnings-growth ratio of 2.06 and a beta of 0.84.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, November 4th. The company reported $1.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.27 by $0.11. The business had revenue of $3.34 billion during the quarter, compared to analysts’ expectations of $3.28 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. Henry Schein has set its FY 2025 guidance at 4.880-4.960 EPS. As a group, equities research analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.